Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents

References

• Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 2016;16:99
   PubMed Web of Science ®Google Scholar
• Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2003;4:721–9.
   PubMed Web of Science ®Google Scholar
• Lopez J, Tait SWG. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer 2015;112:957
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Dumas J, Ladouceur G, Lynch M, Scott W. Diaryl ureas with kinase inhibiting activity. 2007; U.S. Pat 20070020704.
   Google Scholar
• Skårderud MR, Polk A, Vistisen KK, et al. Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: a systematic review. Cancer Treat Rev 2017;62:61–73.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu J. Role of apoptosis in colon cancer biology, therapy, and prevention. Curr Colorectal Cancer Rep 2013;9:331–40.
   Google Scholar
• Chen D, Wei L, Yu J, Zhang L. Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis. Clin Cancer Res. 2014;20:3472–84.
   PubMed Web of Science ®Google Scholar
• Sahu A, Prabhash K, Noronha V, et al. Crizotinib: a comprehensive review. South Asian J Cancer 2013;2:91.
   PubMedGoogle Scholar
• Frampton JE. Crizotinib: a review of its use in the treatment of anaplastic lymphoma kinase-positive, advanced non-small cell lung cancer. Drugs 2013;73:2031–51.
   PubMed Web of Science ®Google Scholar
• Dai X, Guo G, Zou P, et al. (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1. J Exp Clin Cancer Res 2017;36:120.
   PubMed Web of Science ®Google Scholar
• El-Naggar M, Almahli H, Ibrahim HS, et al. Pyridine-ureas as potential anticancer agents: synthesis and in vitro biological evaluation. Molecules 2018;23:1459.
   Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ibrahim HS, et al. Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent antiproliferative agents. J Enz Inhib Med Chem 2018;33:867–78.
   PubMed Web of Science ®Google Scholar
• Sabt A, Abdelhafez OM, El-Haggar RS, et al. Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. J Enz Inhib Med Chem 2018;33:1095–107.
   PubMed Web of Science ®Google Scholar
• Al-Ansary GH, Eldehna WM, Ghabbour HA, et al. Cancer stem cells CD133 inhibition and cytotoxicity of certain 3-phenylthiazolo [3, 2-a] benzimidazoles: design, direct synthesis, crystal study and in vitro biological evaluation. J Enzym Inhib Med Chem 2017;32:986–91.
   PubMed Web of Science ®Google Scholar
• Attia MI, Eldehna WM, Afifi SA, et al. New hydrazonoindolin-2-ones: synthesis, exploration of the possible antiproliferative mechanism of action and encapsulation into PLGA microspheres. PLoS One 2017;12:e0181241.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HA, Eldehna WM, Keeton AB, et al. Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling. Drug Des Dev Ther 2017;11:2333.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Abou-Seri SM, El Kerdawy AM, et al. Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives. Eur J Med Chem 2016;113:50–62.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HA, Ghabbour HA, Eldehna WM, et al. 2-((Benzimidazol-2-yl)thio)-1-arylethan-1-ones: synthesis, crystal study and cancer stem cells CD133 targeting potential. Eur J Med Chem 2015;104:1–10.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HA, Ghabbour HA, Eldehna WM, et al. Synthesis, crystal structure and biological activity of cis/trans amide rotomers of (Z)-N′-(2-oxoindolin-3-ylidene)formohydrazide. J Chem 2014;2014:1. doi:10.1155/2014/760434.
   Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ibrahim HS, et al. Synthesis and cytotoxic activity of biphenylurea derivatives containing indolin-2-one moieties. Molecules 2016;21:762.
   PubMed Web of Science ®Google Scholar
• Soliman DH, Eldehna WM, Ghabbour HA, et al. Novel 6-phenylnicotinohydrazide derivatives: design, synthesis and biological evaluation as a novel class of antitubercular and antimicrobial agents. Biol Pharm Bull 2017;40:1883–93.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Altoukhy A, Mahrous H, Abdel-Aziz HA. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential antiproliferative agents. Eur J Med Chem 2015;90:684–94.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Abdel-Aziz MM, Abdel-Aziz HA. Design, synthesis and antitubercular activity of certain nicotinic acid hydrazides. Molecules 2015;20:8800–15.
   PubMed Web of Science ®Google Scholar
• Boyd MR, Paull KD. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 1995;34:91–109.
   Web of Science ®Google Scholar
• Boyd MR. The NCI human tumor cell line (60-Cell) screen. In: Teicher BA, ed. Cancer drug discovery and development: anticancer drug development guide: preclinical screening, clinical trials and approval. Totowa, NJ: Humana Press; 2014:Chapter 1, 41–62.
   Google Scholar
• Monks A, Scudiero D, Skehan P, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757–66.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl Cancer Inst 1990;82:1107–12.
   PubMed Web of Science ®Google Scholar
• Abou-Seri SM, Eldehna WM, Ali MM, El Ella DAA. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in vitro biological evaluation. Eur J Med Chem 2016;107:165–79.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Ismail RSM, Abou-Seri SM, Eldehna WM, et al. Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells. Eur J Med Chem 2018;155:782–96.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Abo-Ashour MF, Nocentini A, et al. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies. Eur J Med Chem 2017;139:250–62.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Ibrahim HS, Abdel-Aziz HA, et al. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eur J Med Chem 2015;89:549–60.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Nocentini A, Al-Rashood ST, et al. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer. Bioorg Chem 2018;81:425–32.
   PubMed Web of Science ®Google Scholar
• Ghabbour HA, Qabeel MM, Eldehna WM, et al. Design, synthesis, and molecular docking of 1-(1-(4-chlorophenyl)-2-(phenylsulfonyl)ethylidene)-2-phenylhydrazine as potent nonazole anticandidal agent. J Chem 2014;2014:1.
   Web of Science ®Google Scholar
• Eldehna WM, EL-Naggar DH, Hamed AR, et al. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells. J Enzym Inhib Med Chem 2018;33:309–18.
   PubMed Web of Science ®Google Scholar
• Almahli H, Hadchity E, Jaballah MY, et al. Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer. Bioorg Chem 2018;77:443–56.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Abo-Ashour MF, Ibrahim HS, et al. [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferativeagents: design, synthesis and in vitro biological evaluation. J Enzym Inhib Med Chem 2018;33:686–700.
   PubMed Web of Science ®Google Scholar
• El-Naggar M, Eldehna WM, Almahli H, et al. Novel thiazolidinone/thiazolo [3, 2-a] benzimidazolone-isatin conjugates as apoptotic anti-proliferative agents towards breast cancer: one-pot synthesis and in vitro biological evaluation. Molecules 2018;23:1420.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HA, Eldehna WM, Ghabbour H, et al. Synthesis, crystal study, and anti-proliferative activity of some 2-benzimidazolylthioacetophenones towards triple-negative breast cancer MDA-MB-468 cells as apoptosis-inducing agents. Int J Mol Sci 2016;17:1221.
   Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47–59.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhao PJ, Su D, et al. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol Med Rep 2014;9:2265–72.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999;399:483–7.
   PubMed Web of Science ®Google Scholar
• Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030–40.
   PubMed Web of Science ®Google Scholar
• McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013;5:a008656.
   PubMed Web of Science ®Google Scholar
• Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1–16.
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342–8.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39–51.
   PubMed Web of Science ®Google Scholar